Skip to main content

Inflammatory Bowel Disease (IBD) Updates with Dr. Aline Charabaty

The Curbsiders Internal Medicine PodcastOctober 20, 20251h 21min1,485 views
32 connections·40 entities in this video→

Understanding Inflammatory Bowel Disease (IBD)

  • πŸ’‘ IBD is on the rise across all demographics, affecting individuals of all backgrounds, not just Caucasians or those of Jewish descent.
  • 🩺 Early recognition of IBD symptoms, including extraintestinal manifestations, and prompt referral to specialists are crucial to prevent complications and hospitalizations.
  • 🀝 Managing IBD requires a multidisciplinary approach involving internists, gastroenterologists, rheumatologists, surgeons, dietitians, and psychologists.

Diagnostic Approaches and Imaging

  • 🩸 Blood in the stool, even if only on toilet paper, warrants serious evaluation due to rising colon cancer rates in young patients.
  • πŸ”¬ While IBS, lactose intolerance, or celiac disease might be initial thoughts, bleeding and anemia are concerning for IBD.
  • πŸ“Š Inflammatory markers like CRP and fecal calprotectin are important, though not always elevated in flares, and fecal calprotectin is more specific to gut inflammation.
  • πŸ“Έ CT scans can show bowel wall thickening and inflammation, but intestinal ultrasound is a non-invasive, real-time tool for monitoring IBD, especially for Crohn's involving the terminal ileum.

Endoscopic and Pathological Findings

  • πŸ” Endoscopic evaluation for suspected Crohn's disease reveals ulcerations, narrowing (strictures), and potentially skip lesions or patchy inflammation.
  • πŸ”¬ Ulcerative colitis typically presents with continuous inflammation, granular mucosa, and friability, always involving the rectum.
  • 🧬 Pathological findings for IBD require both acute and chronic inflammatory changes, with granulomas being a supportive, though not definitive, sign of Crohn's disease.

Treatment Strategies and Goals

  • πŸ’Š Multiple drug classes are available, including anti-TNF agents, vedolizumab, IL-12/23 inhibitors, and small molecules (JAK inhibitors, S1PR modulators), chosen based on disease severity, location, phenotype, and patient factors.
  • 🎯 Treatment goals have evolved beyond symptom relief to include clinical remission and endoscopic healing, which reduces the risk of flares, complications, and surgery.
  • βš–οΈ Shared decision-making with patients is key, considering their lifestyle, preferences, and goals of care, which extend beyond GI health to overall quality of life.

Diet, Lifestyle, and Preventive Health

  • πŸ₯— While dietary recommendations vary, a healthy diet rich in fiber, fruits, and vegetables, and low in processed foods is generally advised, adapted to individual tolerance and cultural preferences.
  • πŸ’‰ Patients with IBD on immunosuppressive therapy require age-appropriate vaccinations (except live virus vaccines) and annual skin checks due to increased risk of skin cancer.
  • 🦴 Bone density scans are recommended for patients with a history of steroid use or other risk factors for osteopenia and osteoporosis.
  • 🩸 Iron and B12 deficiencies are common, with IV iron often preferred for severe anemia or active inflammation due to impaired oral absorption.

Managing Flares and Extra-intestinal Manifestations

  • 🚨 Acute severe ulcerative colitis requires hospitalization, prompt evaluation for infection (C. diff), IV steroids, fluids, and early surgical consultation.
  • 🩹 Outpatient flares may be managed with oral prednisone while initiating advanced therapies, with IL-23 inhibitors or vedolizumab being common choices.
  • πŸƒ Extra-intestinal manifestations (EIMs), such as joint pain or uveitis, can influence therapy selection, with anti-TNF agents and JAK inhibitors often effective for these conditions.
Knowledge graph40 entities Β· 32 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
40 entities
Chapters19 moments

Key Moments

Transcript299 segments

Full Transcript

Topics23 themes

What’s Discussed

Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisIBD FlaresFecal CalprotectinCRPEndoscopyColonoscopyCT ScanIntestinal UltrasoundBiopsyAnti-TNF TherapyVedolizumabIL-23 InhibitorsJAK InhibitorsDietary ManagementPreventive HealthVaccinationsSkin Cancer ScreeningBone Density ScanIron Deficiency AnemiaVitamin B12 DeficiencyExtra-intestinal Manifestations
Smart Objects40 Β· 32 links
PeopleΒ· 4
ConceptsΒ· 25
ProductsΒ· 5
CompaniesΒ· 4
LocationsΒ· 2